Title: Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories.

Authors: Ash, Jeremy; Fourches, Denis

Published In J Chem Inf Model, (2017 Jun 26)

Abstract: Quantitative Structure-Activity Relationship (QSAR) models typically rely on 2D and 3D molecular descriptors to characterize chemicals and forecast their experimental activities. Previously, we showed that even the most reliable 2D QSAR models and structure-based 3D molecular docking techniques were not capable of accurately ranking a set of known inhibitors for the ERK2 kinase, a key player in various types of cancer. Herein, we calculated and analyzed a series of chemical descriptors computed from the molecular dynamics (MD) trajectories of ERK2-ligand complexes. First, the docking of 87 ERK2 ligands with known binding affinities was accomplished using Schrodinger's Glide software; then, solvent-explicit MD simulations (20 ns, NPT, 300 K, TIP3P, 1 fs) were performed using the GPU-accelerated Desmond program. Second, we calculated a series of MD descriptors based on the distributions of 3D descriptors computed for representative samples of the ligand's conformations over the MD simulations. Third, we analyzed the data set of 87 inhibitors in the MD chemical descriptor space. We showed that MD descriptors (i) had little correlation with conventionally used 2D/3D descriptors, (ii) were able to distinguish the most active ERK2 inhibitors from the moderate/weak actives and inactives, and (iii) provided key and complementary information about the unique characteristics of active ligands. This study represents the largest attempt to utilize MD-extracted chemical descriptors to characterize and model a series of bioactive molecules. MD descriptors could enable the next generation of hyperpredictive MD-QSAR models for computer-aided lead optimization and analogue prioritization.

PubMed ID: 28471171

MeSH Terms: Ligands; Mitogen-Activated Protein Kinase 1/antagonists & inhibitors*; Mitogen-Activated Protein Kinase 1/chemistry; Mitogen-Activated Protein Kinase 1/metabolism; Molecular Dynamics Simulation*; Protein Conformation; Protein Kinase Inhibitors/chemistry*; Protein Kinase Inhibitors/metabolism; Protein Kinase Inhibitors/pharmacology*; Quantitative Structure-Activity Relationship; Solvents/chemistry; Temperature